FBLN1 and neoplasm: In various aspects of tumor cells, such as cell motility (Lee et al., 2005), cell proliferation (Cheng et al., 2008), apoptosis, and angiogenesis (Xie et al., 2008), fibulin-1 (FBLN1) was reported as a novel ECM protein.